Screener
Bio-Techne TECH Diagnostics And Spatial Biology — Goodwill
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bio-Techne in its filing.
Tagged under the XBRL concept us-gaap:Goodwill.
The source filing: Bio-Techne’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056302
FAQ
- What is Bio-Techne's diagnostics and spatial biology — goodwill?
- Bio-Techne (TECH) reported diagnostics and spatial biology — goodwill of $553.62M in Q1 2026.
- How has Bio-Techne's diagnostics and spatial biology — goodwill changed year-over-year?
- Bio-Techne's diagnostics and spatial biology — goodwill increased by 1.1% year-over-year, from $547.5M to $553.62M.
- What does diagnostics and spatial biology — goodwill mean?
- Represents the excess of the purchase price over the fair value of identifiable net assets acquired in business combinations within the diagnostics and spatial biology segment. This intangible asset reflects the premium paid for brand reputation, customer relationships, and proprietary technology. It is subject to periodic impairment testing to ensure the carrying value remains supported by future cash flows.
Ask your AI about Bio-Techne's diagnostics and spatial biology — goodwill.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude